Most people with prostates experience a rise in PSA levels as they age. There's no evidence that treatment, especially given how slow, growing prostate cancer usually is, results in a net positive benefit overall. The exception is younger people with aggressive cancer, but you can't exactly limit PSA screening only to young people with aggressive prostate cancer.